- Home
- SANA vs SIGA Comparison
SANA vs SIGA Comparison
Compare SANA & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANA
- SIGA
- Stock Information
- Founded
- SANA 2018
- SIGA 1995
- Country
- SANA United States
- SIGA United States
- Employees
- SANA N/A
- SIGA N/A
- Industry
- SANA Medicinal Chemicals and Botanical Products
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- SANA Health Care
- SIGA Health Care
- Exchange
- SANA Nasdaq
- SIGA Nasdaq
- Market Cap
- SANA 519.8M
- SIGA 422.9M
- IPO Year
- SANA 2021
- SIGA 1997
- Fundamental
- Price
- SANA $2.17
- SIGA $5.98
- Analyst Decision
- SANA Strong Buy
- SIGA
- Analyst Count
- SANA 5
- SIGA 0
- Target Price
- SANA $9.50
- SIGA N/A
- AVG Volume (30 Days)
- SANA 3.9M
- SIGA 456.1K
- Earning Date
- SANA 05-08-2025
- SIGA 05-08-2025
- Dividend Yield
- SANA N/A
- SIGA 10.03%
- EPS Growth
- SANA N/A
- SIGA N/A
- EPS
- SANA N/A
- SIGA 0.67
- Revenue
- SANA N/A
- SIGA $120,330,310.00
- Revenue This Year
- SANA N/A
- SIGA N/A
- Revenue Next Year
- SANA N/A
- SIGA $95.31
- P/E Ratio
- SANA N/A
- SIGA $8.91
- Revenue Growth
- SANA N/A
- SIGA N/A
- 52 Week Low
- SANA $1.26
- SIGA $4.95
- 52 Week High
- SANA $8.17
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- SANA 59.16
- SIGA 51.85
- Support Level
- SANA $1.81
- SIGA $5.71
- Resistance Level
- SANA $2.35
- SIGA $6.23
- Average True Range (ATR)
- SANA 0.21
- SIGA 0.21
- MACD
- SANA 0.05
- SIGA 0.02
- Stochastic Oscillator
- SANA 76.00
- SIGA 51.92
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.